Ethic Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Buy |
11,495
+58
| +0.5% | +$25.6K | 0.09% | 233 |
|
|
2025
Q1 | $5.54M | Sell |
11,437
-11,553
| -50% | -$5.6M | 0.11% | 201 |
|
|
2024
Q4 | $9.26M | Buy |
22,990
+3,197
| +16% | +$1.29M | 0.19% | 107 |
|
|
2024
Q3 | $8.27M | Sell |
19,793
-1,369
| -6% | -$572K | 0.21% | 99 |
|
|
2024
Q2 | $9.92M | Buy |
21,162
+1,369
| +7% | +$642K | 0.23% | 82 |
|
|
2024
Q1 | $8.27M | Buy |
19,793
+2,157
| +12% | +$902K | 0.21% | 99 |
|
|
2023
Q4 | $7.18M | Buy |
17,636
+1,131
| +7% | +$460K | 0.21% | 99 |
|
|
2023
Q3 | $5.74M | Buy |
16,505
+1,769
| +12% | +$615K | 0.2% | 108 |
|
|
2023
Q2 | $5.19M | Buy |
14,736
+1,422
| +11% | +$500K | 0.19% | 123 |
|
|
2023
Q1 | $4.19M | Buy |
13,314
+4,611
| +53% | +$1.45M | 0.17% | 152 |
|
|
2022
Q4 | $2.51M | Buy |
8,703
+1,372
| +19% | +$396K | 0.14% | 196 |
|
|
2022
Q3 | $2.12M | Buy |
7,331
+1,326
| +22% | +$384K | 0.14% | 175 |
|
|
2022
Q2 | $1.69M | Buy |
6,005
+3,656
| +156% | +$1.03M | 0.12% | 226 |
|
|
2022
Q1 | $613K | Buy |
2,349
+157
| +7% | +$41K | 0.04% | 410 |
|
|
2021
Q4 | $481K | Sell |
2,192
-1,894
| -46% | -$416K | 0.04% | 420 |
|
|
2021
Q3 | $741K | Sell |
4,086
-124
| -3% | -$22.5K | 0.08% | 278 |
|
|
2021
Q2 | $849K | Buy |
4,210
+749
| +22% | +$151K | 0.1% | 240 |
|
|
2021
Q1 | $744K | Buy |
3,461
+966
| +39% | +$208K | 0.13% | 196 |
|
|
2020
Q4 | $590K | Sell |
2,495
-104
| -4% | -$24.6K | 0.16% | 169 |
|
|
2020
Q3 | $707K | Buy |
2,599
+231
| +10% | +$62.8K | 0.27% | 97 |
|
|
2020
Q2 | $687K | Buy |
2,368
+1,420
| +150% | +$412K | 0.39% | 60 |
|
|
2020
Q1 | $226K | Buy |
+948
| New | +$226K | 0.19% | 166 |
|